BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

997 related articles for article (PubMed ID: 29858360)

  • 21. Comparison of global and regional myocardial strains in patients with heart failure with a preserved ejection fraction vs hypertension vs age-matched control.
    Kim HY; Park SJ; Lee SC; Chang SY; Kim EK; Chang SA; Choi JO; Park SW; Kim SM; Choe YH; Oh JK
    Cardiovasc Ultrasound; 2020 Nov; 18(1):44. PubMed ID: 33172479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.
    Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction.
    Hamdani N; Bishu KG; von Frieling-Salewsky M; Redfield MM; Linke WA
    Cardiovasc Res; 2013 Mar; 97(3):464-71. PubMed ID: 23213108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Predictors of Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Preclinical Left Ventricular Diastolic Dysfunction.
    Zhang L; Liebelt JJ; Madan N; Shan J; Taub CC
    Am J Cardiol; 2017 Jun; 119(11):1815-1820. PubMed ID: 28450040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term prescription of beta-blocker delays the progression of heart failure with preserved ejection fraction in patients with hypertension: A retrospective observational cohort study.
    Gu J; Fan YQ; Bian L; Zhang HL; Xu ZJ; Zhang Y; Chen QZ; Yin ZF; Xie YS; Wang CQ
    Eur J Prev Cardiol; 2016 Sep; 23(13):1421-8. PubMed ID: 26915580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
    Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
    Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a robust mouse model of heart failure with preserved ejection fraction.
    Matsiukevich D; Kovacs A; Li T; Kokkonen-Simon K; Matkovich SJ; Oladipupo SS; Ornitz DM
    Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H203-H231. PubMed ID: 37204871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of speckle tracking to assess heart failure with preserved ejection fraction.
    Hiebert JB; Vacek J; Shah Z; Rahman F; Pierce JD
    J Cardiol; 2019 Nov; 74(5):397-402. PubMed ID: 31303358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reverse electrical remodeling in rats with heart failure and preserved ejection fraction.
    Cho JH; Kilfoil PJ; Zhang R; Solymani RE; Bresee C; Kang EM; Luther K; Rogers RG; de Couto G; Goldhaber JI; Marbán E; Cingolani E
    JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction.
    Packer M
    J Card Fail; 2019 Dec; 25(12):986-1003. PubMed ID: 31541742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel predictor of clinical outcomes in patients with heart failure with preserved left-ventricular ejection fraction: a pilot study.
    Kanda T; Uematsu M; Fujita M; Iida O; Masuda M; Okamoto S; Ishihara T; Nanto K; Tsujimura T; Matsuda Y; Okuno S; Mano T
    Heart Vessels; 2018 Dec; 33(12):1490-1495. PubMed ID: 29934800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A transmural gradient of myocardial remodeling in early-stage heart failure with preserved ejection fraction in the pig.
    Mühlfeld C; Rajces A; Manninger M; Alogna A; Wierich MC; Scherr D; Post H; Schipke J
    J Anat; 2020 Mar; 236(3):531-539. PubMed ID: 31749243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.
    Toledo C; Andrade DC; Lucero C; Arce-Alvarez A; Díaz HS; Aliaga V; Schultz HD; Marcus NJ; Manríquez M; Faúndez M; Del Rio R
    J Physiol; 2017 Apr; 595(8):2479-2495. PubMed ID: 28181258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion.
    Van Aelst LNL; Arrigo M; Placido R; Akiyama E; Girerd N; Zannad F; Manivet P; Rossignol P; Badoz M; Sadoune M; Launay JM; Gayat E; Lam CSP; Cohen-Solal A; Mebazaa A; Seronde MF
    Eur J Heart Fail; 2018 Apr; 20(4):738-747. PubMed ID: 29251818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.
    Zhou L; Filiberti A; Humphrey MB; Fleming CD; Scherlag BJ; Po SS; Stavrakis S
    Exp Physiol; 2019 Jan; 104(1):28-38. PubMed ID: 30398289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of heart failure with preserved ejection fraction.
    Dulce RA; Kanashiro-Takeuchi RM; Takeuchi LM; Salerno AG; Wanschel ACBA; Kulandavelu S; Balkan W; Zuttion MSSR; Cai R; Schally AV; Hare JM
    Cardiovasc Res; 2023 Feb; 118(18):3586-3601. PubMed ID: 35704032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular and Molecular Differences between HFpEF and HFrEF: A Step Ahead in an Improved Pathological Understanding.
    Simmonds SJ; Cuijpers I; Heymans S; Jones EAV
    Cells; 2020 Jan; 9(1):. PubMed ID: 31963679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic low-intensity exercise attenuates cardiomyocyte contractile dysfunction and impaired adrenergic responsiveness in aortic-banded mini-swine.
    Hiemstra JA; Veteto AB; Lambert MD; Olver TD; Ferguson BS; McDonald KS; Emter CA; Domeier TL
    J Appl Physiol (1985); 2018 Apr; 124(4):1034-1044. PubMed ID: 29357490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The differences in the relationship between diastolic dysfunction, selected biomarkers and collagen turn-over in heart failure patients with preserved and reduced ejection fraction.
    Michalski B; Trzciński P; Kupczyńska K; Miśkowiec D; Pęczek Ł; Nawrot B; Lipiec P; Kasprzak JD
    Cardiol J; 2017; 24(1):35-42. PubMed ID: 27748500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.